Which cancer type first approved keytruda by fda?

Question

Which cancer type first approved keytruda by fda?

Other Questions About Keytruda : When did fda approve keytruda for widespread cancer treatment? Can you recall keytruda s fda approval date? What s the exact date of keytruda s first fda approval?

Accepted Answer

See the DrugPatentWatch profile for keytruda

Keytruda, a drug produced by Merck & Co., was first approved by the U.S. Food and Drug Administration (FDA) for the treatment of melanoma, the most dangerous type of skin cancer [1].

Keytruda, also known as pembrolizumab, is a type of immunotherapy that helps the body's immune system fight cancer [1]. It was approved by the FDA for the treatment of melanoma in September 2014 [1].

According to DrugPatentWatch.com, Keytruda was approved for the treatment of melanoma in patients who have already been treated with other drugs [2]. Additionally, Keytruda was the first anti-PD-1 therapy approved by the FDA for the treatment of melanoma [2].

In summary, Keytruda was first approved by the FDA for the treatment of melanoma, a dangerous type of skin cancer. It was approved in September 2014 for the treatment of melanoma patients who have already been treated with other drugs. Keytruda was the first anti-PD-1 therapy approved by the FDA for the treatment of melanoma.

Sources:
[1] "FDA approves new treatment for advanced skin cancer." U.S. Food and Drug Administration. <https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-advanced-skin-cancer>.
[2] "Keytruda (pembrolizumab)." DrugPatentWatch.com. <https://www.drugpatentwatch.com/drugs/keytruda>.

Ask Anything...

Recent Questions

Which cancer type first approved keytruda by fda?